Dianthus Therapeutics | MGTA - Debt

Stock Price
86.16
Daily Change
0.82 0.96%
Monthly
-7.26%
Yearly
337.58%
Q2 Forecast
84.43

Dianthus Therapeutics reported $1.28M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Avita Medical AUD 46.05M 1.46M Dec/2025
Celltrion KRW 161.31B 9.78B Dec/2025
Cspc Pharmaceutical CNY 495M 12.33M Jun/2025
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Divis Laboratories Ltd INR 40M 40M Mar/2025
IQVIA Holdings USD 15.83B 109M Mar/2026
Kangmei Pharma CNY 131.64M 90.18M Jun/2025
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 100K 0 Dec/2023
Medical Developments International AUD 1.99M 152K Jun/2025
Moderna USD 1.31B 571M Dec/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organon & Co USD 8.64B 184M Dec/2025
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 47.54M 1.88M Mar/2026
Qiagen NV USD 1.81B 314.82M Dec/2025
Revvity USD 3.4B 29.2M Dec/2025
Sartorius EUR 4.28B 372.9M Dec/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Tectonic Therapeutic USD 876K 115K Dec/2024
Tilray USD 640.95M 35.17M Jun/2022
Viatris USD 14.34B 69.3M Mar/2026
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025
Zz Pientze Pharmaceu CNY 1.07B 2.82M Mar/2026